Theodore J. Witek, Jr
2017
In 2017, Theodore J. Witek, Jr earned a total compensation of $1.7M as Senior Vice President and Chief Scientific Officer Clinical and Medical Affairs at Innoviva, a 22% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $217,670 |
|---|---|
| Salary | $435,340 |
| Stock Awards | $999,678 |
| Other | $31,983 |
| Total | $1,684,671 |
Witek received $999.7K in stock awards, accounting for 59% of the total pay in 2017.
Witek also received $217.7K in non-equity incentive plan, $435.3K in salary and $32K in other compensation.
Rankings
In 2017, Theodore J. Witek, Jr's compensation ranked 6,372nd out of 14,666 executives tracked by ExecPay. In other words, Witek earned more than 56.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,372 out of 14,666 | 57th |
Division Manufacturing | 2,349 out of 5,772 | 59th |
Major group Chemicals And Allied Products | 747 out of 2,075 | 64th |
Industry group Drugs | 577 out of 1,731 | 67th |
Industry Pharmaceutical Preparations | 456 out of 1,333 | 66th |
Source: SEC filing on March 23, 2018.
Witek's colleagues
We found four more compensation records of executives who worked with Theodore J. Witek, Jr at Innoviva in 2017.